Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals

详细信息    查看全文

• 作者：Edward J Mills (1)
  Ping Wu (2)
  Ian Lockhart (3)
  Kumanan Wilson (4)
  Jon O Ebbert (5)
  
• 刊名：Tobacco Induced Diseases
• 出版年：2010
• 出版时间：December 2010
• 年：2010
• 卷：8
• 期：1
• 全文大小：1140KB
• 参考文献：1. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr, Doll R: Mortality from smoking worldwide. / Br Med Bull 1996, 52:12鈥?1.
  2. Doll R, Peto R, Wheatley K, Gray R, Sutherland I: Mortality in relation to smoking: 40 years' observations on male British doctors. / Bmj 1994, 309:901鈥?1.
  3. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R: Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. / Lancet 2007, 370:2044鈥?3.
  4. Wu P, Wilson K, Dimoulas P, Mills EJ: Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. / BMC Public Health 2006, 6:300.
  5. NICE: Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women and hard to reach communities. Public Health Guidance PH10. [http://www.nice.org.uk/guidance/index.jsp?action=byID&o=11925] 2008.
  6. Eisenberg MJ, Filion KB, Yavin D, Belisle P, Mottillo S, Joseph L, / et al.: Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. / Cmaj 2008, 179:135鈥?4.
  7. Vjogt F, Hall S, Marteau TM: Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies. / Nicotine Tob Res 2008, 10:1405鈥?3.
  8. Hughes JR: Effects of abstinence from tobacco: valid symptoms and time course. / Nicotine Tob Res 2007, 9:315鈥?7.
  9. Chou R, Helfand M: Challenges in systematic reviews that assess treatment harms. / Ann Intern Med 2005, 142:1090鈥?.
  10. Kuper H, Nicholson A, Hemingway H: Searching for observational studies: what does citation tracking add to PubMed? A case study in depression and coronary heart disease. / BMC medical research methodology 2006, 6:4.
  11. Tonnesen P: Smoking cessation: How compelling is the evidence? A review. / Health policy (Amsterdam, Netherlands) 2009,91(Suppl 1):S15鈥?5.
  12. Mills EJ, Wu P, Spurden D, Ebbert JO, Wilson K: Efficacy of pharmacotherapies for short-term smoking abstinance: A systematic review and meta-analysis. / Harm Reduct J 2009, 6:25.
  13. Stead LF, Perera R, Bullen C, Mant D, Lancaster T: Nicotine replacement therapy for smoking cessation. / Cochrane database of systematic reviews (Online) 2008, CD000146.
  14. Stead LF, Lancaster T: Interventions to reduce harm from continued tobacco use. / Cochrane database of systematic reviews (Online) 2007, CD005231.
  15. Cahill K, Stead LF, Lancaster T: Nicotine receptor partial agonists for smoking cessation. / Cochrane database of systematic reviews (Online) 2007, CD006103.
  16. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ, / et al.: The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. / Health technology assessment (Winchester, England) 2002, 6:1鈥?45.
  17. Meade MO, Guyatt GH, Cook RJ, Groll R, Kachura JR, Wigg M, / et al.: Agreement between alternative classifications of acute respiratory distress syndrome. / Am J Respir Crit Care Med 2001, 163:490鈥?.
  18. Sheehe PR: Combination of log relative risk in retrospective studies of disease. / Am J Public Health Nations Health 1966, 56:1745鈥?0.
  19. DerSimonian R, Laird N: Meta-analysis in clinical trials. / Control Clin Trials 1986, 7:177鈥?8.
  20. Fleiss JL: The statistical basis of meta-analysis. / Stat Methods Med Res 1993, 2:121鈥?5.
  21. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. / Stat Med 2002, 21:1539鈥?8.
  22. Stuart A, Ord JK: / Kendall's Advanced Theory of Statistics. 6th edition. London: Edward Arnold; 1994.
  23. Borenstin M, Hedges L, Higgins JP, Rothstein H: / Introduction to Meta-analysis. Wiley, Chichester; 2009:312.
  24. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, / et al.: Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. / PLoS medicine 2006, 3:e438.
  25. Rucker G, Schwarzer G, Carpenter JR, Schumacher M: Undue reliance on I(2) in assessing heterogeneity may mislead. / BMC medical research methodology 2008, 8:79.
  26. Malcolm RE, Sillett RW, Turner JA, Ball KP: The use of nicotine chewing gum as an aid to stopping smoking. / Psychopharmacology (Berl) 1980, 70:295鈥?.
  27. Jarvis MJ, Raw M, Russell MA, Feyerabend C: Randomised controlled trial of nicotine chewing-gum. / Br Med J (Clin Res Ed) 1982, 285:537鈥?0.
  28. Fagerstrom KO: A comparison of psychological and pharmacological treatment in smoking cessation. / J Behav Med 1982, 5:343鈥?1.
  29. Comparison of four methods of smoking withdrawal in patients with smoking related diseases. Report by a subcommittee of the Research Committee of the British Thoracic Society / Br Med J (Clin Res Ed) 1983, 286:595鈥?.
  30. Schneider NG, Jarvik ME, Forsythe AB, Read LL, Elliott ML, Schweiger A: Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial. / Addict Behav 1983, 8:253鈥?1.
  31. Jamrozik K, Fowler G, Vessey M, Wald N: Placebo controlled trial of nicotine chewing gum in general practice. / Br Med J (Clin Res Ed) 1984, 289:794鈥?.
  32. Tonnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H, / et al.: Two and four mg nicotine chewing gum and group counselling in smoking cessation: an open, randomized, controlled trial with a 22 month follow-up. / Addict Behav 1988, 13:17鈥?7.
  33. Areechon W, Punnotok J: Smoking cessation through the use of nicotine chewing gum: a double-blind trial in Thailand. / Clin Ther 1988, 10:183鈥?.
  34. Fortmann SP, Killen JD, Telch MJ, Newman B: Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project. / Jama 1988, 260:1575鈥?0.
  35. Harackiewicz JM, Blair LW, Sansone C, Epstein JA, Stuchell RN: Nicotine gum and self-help manuals in smoking cessation: an evaluation in a medical context. / Addict Behav 1988, 13:319鈥?0.
  36. Tonnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H, / et al.: Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. / N Engl J Med 1988, 318:15鈥?.
  37. Hughes JR, Gust SW, Keenan RM, Fenwick JW, Healey ML: Nicotine vs placebo gum in general medical practice. / Jama 1989, 261:1300鈥?.
  38. Blondal T: Controlled trial of nicotine polacrilex gum with supportive measures. / Arch Intern Med 1989, 149:1818鈥?1.
  39. Abelin T, Ehrsam R, Buhler-Reichert A, Imhof PR, Muller P, Thommen A, / et al.: Effectiveness of a transdermal nicotine system in smoking cessation studies. / Methods Find Exp Clin Pharmacol 1989, 11:205鈥?4.
  40. Hurt RD, Lauger GG, Offord KP, Kottke TE, Dale LC: Nicotine-replacement therapy with use of a transdermal nicotine patch--a randomized double-blind placebo-controlled trial. / Mayo Clin Proc 1990, 65:1529鈥?7.
  41. Tonnesen P, Norregaard J, Simonsen K, Sawe U: A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. / N Engl J Med 1991, 325:311鈥?.
  42. Campbell IA, Prescott RJ, Tjeder-Burton SM: Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum. / Respir Med 1991, 85:155鈥?.
  43. Daughton DM, Heatley SA, Prendergast JJ, Causey D, Knowles M, Rolf CN, / et al.: Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. / Arch Intern Med 1991, 151:749鈥?2.
  44. Sutherland G, Stapleton JA, Russell MA, Jarvis MJ, Hajek P, Belcher M, / et al.: Randomised controlled trial of nasal nicotine spray in smoking cessation. / Lancet 1992, 340:324鈥?.
  45. Sachs DP, Sawe U, Leischow SJ: Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. / Arch Intern Med 1993, 153:1881鈥?0.
  46. Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F: A double-blind trial of a nicotine inhaler for smoking cessation. / Jama 1993, 269:1268鈥?1.
  47. Merz PG, Keller-Stanislawski B, Huber T, Woodcock BG, Rietbrock N: Transdermal nicotine in smoking cessation and involvement of non-specific influences. / Int J Clin Pharmacol Ther Toxicol 1993, 31:476鈥?2.
  48. Russell MA, Stapleton JA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, / et al.: Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. / Bmj 1993, 306:1308鈥?2.
  49. Westman EC, Levin ED, Rose JE: The nicotine patch in smoking cessation. A randomized trial with telephone counseling. / Arch Intern Med 1993, 153:1917鈥?3.
  50. Hjalmarson A, Franzon M, Westin A, Wiklund O: Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. / Arch Intern Med 1994, 154:2567鈥?2.
  51. Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, / et al.: Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. / Jama 1994, 271:595鈥?00.
  52. Fiore MC, Kenford SL, Jorenby DE, Wetter DW, Smith SS, Baker TB: Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. / Chest 1994, 105:524鈥?3.
  53. Richmond RL, Harris K, de Almeida Neto A: The transdermal nicotine patch: results of a randomised placebo-controlled trial. / Med J Aust 1994, 161:130鈥?.
  54. Levin ED, Westman EC, Stein RM, Carnahan E, Sanchez M, Herman S, / et al.: Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. / J Clin Psychopharmacol 1994, 14:41鈥?.
  55. Stapleton JA, Russell MA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, / et al.: Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. / Addiction 1995, 90:31鈥?2.
  56. Herrera N, Franco R, Herrera L, Partidas A, Rolando R, Fagerstrom KO: Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. / Chest 1995, 108:447鈥?1.
  57. Schneider NG, Olmstead R, Mody FV, Doan K, Franzon M, Jarvik ME, / et al.: Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. / Addiction 1995, 90:1671鈥?2.
  58. Puska PKH, Vartiainen E, Urjanheimo E: Combined use of nicotine patch and gum compared with gum alone in smoking cessation: a clinical trial in North Karelia. / Tabacco Control 1995, 4:231鈥?.
  59. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G: Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. / Prev Med 1995, 24:41鈥?.
  60. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR: High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. / Jama 1995, 274:1353鈥?.
  61. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ: Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. / Bmj 1995, 311:363鈥?.
  62. Leischow SJN, Franzo F, Hill M, Otte A, Merikle P, E P: Efficacy of the Nicotine Inhaler as an Adjunct to Smoking Cessation. / American Journal of Health Behavior 1996, 20:364鈥?1.
  63. Schneider NG, Olmstead R, Nilsson F, Mody FV, Franzon M, Doan K: Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. / Addiction 1996, 91:1293鈥?06.
  64. Paoletti P, Fornai E, Maggiorelli F, Puntoni R, Viegi G, Carrozzi L, / et al.: Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. / Eur Respir J 1996, 9:643鈥?1.
  65. Blondal T, Franzon M, Westin A: A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. / Eur Respir J 1997, 10:1585鈥?0.
  66. Campbell IA, Prescott RJ, Tjeder-Burton SM: Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. / Respir Med 1996, 90:47鈥?1.
  67. Hjalmarson A, Nilsson F, Sjostrom L, Wiklund O: The nicotine inhaler in smoking cessation. / Arch Intern Med 1997, 157:1721鈥?.
  68. Sonderskov J, Olsen J, Sabroe S, Meillier L, Overvad K: Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. / Am J Epidemiol 1997, 145:309鈥?8.
  69. Perng RP, Hsieh WC, Chen YM, Lu CC, Chiang SJ: Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation. / J Formos Med Assoc 1998, 97:547鈥?1.
  70. Ahluwalia JS, McNagny SE, Clark WS: Smoking cessation among inner-city African Americans using the nicotine transdermal patch. / J Gen Intern Med 1998, 13:1鈥?.
  71. Lewis SF, Piasecki TM, Fiore MC, Anderson JE, Baker TB: Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. / Prev Med 1998, 27:296鈥?03.
  72. Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A: Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. / Arch Fam Med 1998, 7:569鈥?4.
  73. Blondal T, Gudmundsson LJ, Olafsdottir I, Gustavsson G, Westin A: Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. / Bmj 1999, 318:285鈥?.
  74. Tonnesen P, Paoletti P, Gustavsson G, Russell MA, Saracci R, Gulsvik A, / et al.: Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. / Eur Respir J 1999, 13:238鈥?6.
  75. Hays JT, Croghan IT, Schroeder DR, Offord KP, Hurt RD, Wolter TD, / et al.: Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. / Am J Public Health 1999, 89:1701鈥?.
  76. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, / et al.: A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. / N Engl J Med 1999, 340:685鈥?1.
  77. Bohadana A, Nilsson F, Rasmussen T, Martinet Y: Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. / Arch Intern Med 2000, 160:3128鈥?4.
  78. Bolliger CT, Zellweger JP, Danielsson T, van Biljon X, Robidou A, Westin A, / et al.: Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. / Bmj 2000, 321:329鈥?3.
  79. Garvey AJ, Kinnunen T, Nordstrom BL, Utman CH, Doherty K, Rosner B, / et al.: Effects of nicotine gum dose by level of nicotine dependence. / Nicotine Tob Res 2000, 2:53鈥?3.
  80. Wallstrom M, Nilsson F, Hirsch JM: A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. / Addiction 2000, 95:1161鈥?1.
  81. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ: Nicotine patches for pregnant smokers: A randomized controlled study. / Obstet Gynecol 2000, 96:967鈥?1.
  82. Etter JF, Laszlo E, Zellweger JP, Perrot C, Perneger TV: Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial. / J Clin Psychopharmacol 2002, 22:487鈥?5.
  83. Shiffman S, Gorsline J, Gorodetzky CW: Efficacy of over-the-counter nicotine patch. / Nicotine Tob Res 2002, 4:477鈥?3.
  84. Glover ED, Glover PN, Franzon M, Sullivan CR, Cerullo CC, Howell RM, / et al.: A comparison of a nicotine sublingual tablet and placebo for smoking cessation. / Nicotine Tob Res 2002, 4:441鈥?0.
  85. Shiffman S, Dresler CM, Hajek P, Gilburt SJ, Targett DA, Strahs KR: Efficacy of a nicotine lozenge for smoking cessation. / Arch Intern Med 2002, 162:1267鈥?6.
  86. Hand S, Edwards S, Campbell IA, Cannings R: Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support. / Thorax 2002, 57:715鈥?.
  87. Glavas D, Rumboldt M, Rumboldt Z: Smoking cessation with nicotine replacement therapy among health care workers: randomized double-blind study. / Croat Med J 2003, 44:219鈥?4.
  88. Wennike P, Danielsson T, Landfeldt B, Westin A, Tonnesen P: Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. / Addiction 2003, 98:1395鈥?02.
  89. Hughes JR, Novy P, Hatsukami DK, Jensen J, Callas PW: Efficacy of nicotine patch in smokers with a history of alcoholism. / Alcohol Clin Exp Res 2003, 27:946鈥?4.
  90. Hanson K, Allen S, Jensen S, Hatsukami D: Treatment of adolescent smokers with the nicotine patch. / Nicotine Tob Res 2003, 5:515鈥?6.
  91. Molyneux A, Lewis S, Leivers U, Anderton A, Antoniak M, Brackenridge A, / et al.: Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. / Thorax 2003, 58:484鈥?.
  92. Smith SS, Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, / et al.: Targeting smokers at increased risk for relapse: treating women and those with a history of depression. / Nicotine Tob Res 2003, 5:99鈥?09.
  93. Schuurmans MM, Diacon AH, van Biljon X, Bolliger CT: Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial. / Addiction 2004, 99:634鈥?0.
  94. Moolchan ET, Robinson ML, Ernst M, Cadet JL, Pickworth WB, Heishman SJ, / et al.: Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. / Pediatrics 2005, 115:e407鈥?4.
  95. Batra A, Klingler K, Landfeldt B, Friederich HM, Westin A, Danielsson T: Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study. / Clin Pharmacol Ther 2005, 78:689鈥?6.
  96. Rennard SI, Glover ED, Leischow S, Daughton DM, Glover PN, Muramoto M, / et al.: Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial. / Nicotine Tob Res 2006, 8:555鈥?4.
  97. Tonnesen P, Mikkelsen K, Bremann L: Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. / Chest 2006, 130:334鈥?2.
  98. Hotham ED, Gilbert AL, Atkinson ER: A randomised-controlled pilot study using nicotine patches with pregnant women. / Addict Behav 2006, 31:641鈥?.
  99. Myung SK, Seo HG, Park S, Kim Y, Kim DJ, Lee do H, / et al.: Sociodemographic and smoking behavioral predictors associated with smoking cessation according to follow-up periods: a randomized, double-blind, placebo-controlled trial of transdermal nicotine patches. / J Korean Med Sci 2007, 22:1065鈥?0.
  100. Covey LS, Glassman AH, Jiang H, Fried J, Masmela J, LoDuca C, / et al.: A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. / Addiction 2007, 102:1292鈥?02.
  101. Piper ME, Federman EB, McCarthy DE, Bolt DM, Smith SS, Fiore MC, / et al.: Efficacy of bupropion alone and in combination with nicotine gum. / Nicotine Tob Res 2007, 9:947鈥?4.
  102. Oncken C, Cooney J, Feinn R, Lando H, Kranzler HR: Transdermal nicotine for smoking cessation in postmenopausal women. / Addict Behav 2007, 32:296鈥?09.
  103. Uyar M, Filiz A, Bayram N, Elbek O, Herken H, Topcu A, / et al.: A randomized trial of smoking cessation. Medication versus motivation. / Saudi Med J 2007, 28:922鈥?.
  104. Pollak KI, Oncken CA, Lipkus IM, Lyna P, Swamy GK, Pletsch PK, / et al.: Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. / Am J Prev Med 2007, 33:297鈥?05.
  105. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, / et al.: The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. / N Engl J Med 1996, 335:1792鈥?.
  106. Buchkremer G, Bents H, Minneker E, Opitz K: Long-term effects of a combination of transdermal nicotine administration with behavior therapy for smoking cessation. / Nervenarzt 1988, 59:488鈥?0.
  107. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group / Jama 1991, 266:3133鈥?.
  108. Jensen EJ, Schmidt E, Pedersen B, Dahl R: Effect of nicotine, silver acetate, and ordinary chewing gum in combination with group counselling on smoking cessation. / Thorax 1990, 45:831鈥?.
  109. Hughes JR, Gust SW, Keenan RM, Fenwick JW: Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects. / J Pharmacol Exp Ther 1990, 252:1175鈥?3.
  110. Aubin HJ, Bobak A, Britton JR, Oncken C, Billing CB Jr, Gong J, / et al.: Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. / Thorax 2008, 63:717鈥?4.
  111. Rubinstein ML, Benowitz NL, Auerback GM, Moscicki AB: A randomized trial of nicotine nasal spray in adolescent smokers. / Pediatrics 2008, 122:e595鈥?00.
  112. Warner DO, Patten CA, Ames SC, Offord KP, Schroeder DR: Effect of nicotine replacement therapy on stress and smoking behavior in surgical patients. / Anesthesiology 2005, 102:1138鈥?6.
  113. Murray RP, Bailey WC, Daniels K, Bjornson WM, Kurnow K, Connett JE, / et al.: Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. / Chest 1996, 109:438鈥?5.
  114. Sun HQ, Guo S, Chen DF, Jiang ZN, Liu Y, Di XL, / et al.: Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers. / Am J Drug Alcohol Abuse 2009, 35:183鈥?.
  115. Rigotti NA, Gonzales D, Dale LC, Lawrence D, Chang Y: A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain. / Addiction 2009, 104:266鈥?6.
  116. Shiffman S, Ferguson SG, Strahs KR: Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. / Am J Prev Med 2009, 36:96鈥?04. e1
  117. Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, / et al.: A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. / Arch Gen Psychiatry 2009, 66:1253鈥?2.
  118. Hilleman DE, Mohiuddin SM, Delcore MG: Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation. / J Clin Pharmacol 1994, 34:222鈥?.
  119. Orleans CT, Resch N, Noll E, Keintz MK, Rimer BK, Brown TV, / et al.: Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users. / Jama 1994, 271:601鈥?.
  120. Smith TM, Winters FD: Smoking cessation: a clinical study of the transdermal nicotine patch. / J Am Osteopath Assoc 1995, 95:655鈥?. 61鈥?
  121. Martin PD, Robinson GM: The safety, tolerability and efficacy of transdermal nicotine (Nicotinell TTS) in initially hospitalised patients. / N Z Med J 1995, 108:6鈥?.
  122. Fredrickson PA, Hurt RD, Lee GM, Wingender L, Croghan IT, Lauger G, / et al.: High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. / Psychopharmacology (Berl) 1995, 122:215鈥?2.
  123. Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan IT, / et al.: Varying nicotine patch dose and type of smoking cessation counseling. / Jama 1995, 274:1347鈥?2.
  124. Smith TA, House RF Jr, Croghan IT, Gauvin TR, Colligan RC, Offord KP, / et al.: Nicotine patch therapy in adolescent smokers. / Pediatrics 1996, 98:659鈥?7.
  125. Hurt RD, Dale LC, Croghan GA, Croghan IT, Gomez-Dahl LC, Offord KP: Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels. / Mayo Clin Proc 1998, 73:118鈥?5.
  126. Gourlay SG, Forbes A, Marriner T, McNeil JJ: Predictors and timing of adverse experiences during trandsdermal nicotine therapy. / Drug Saf 1999, 20:545鈥?5.
  127. Killen JD, Fortmann SP, Davis L, Strausberg L, Varady A: Do heavy smokers benefit from higher dose nicotine patch therapy? / Exp Clin Psychopharmacol 1999, 7:226鈥?3.
  128. Hurt RD, Croghan GA, Beede SD, Wolter TD, Croghan IT, Patten CA: Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. / Arch Pediatr Adolesc Med 2000, 154:31鈥?.
  129. Shiffman S, Rolf CN, Hellebusch SJ, Gorsline J, Gorodetzky CW, Chiang YK, / et al.: Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. / Addiction 2002, 97:505鈥?6.
  130. Croghan GA, Sloan JA, Croghan IT, Novotny P, Hurt RD, DeKrey WL, / et al.: Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting. / Nicotine Tob Res 2003, 5:181鈥?.
  131. Hasford J, Fagerstrom KO, Haustein KO: A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch. Cohort study on smoking cessation. / Eur J Clin Pharmacol 2003, 59:443鈥?.
  132. Fiore MC, McCarthy DE, Jackson TC, Zehner ME, Jorenby DE, Mielke M, / et al.: Integrating smoking cessation treatment into primary care: an effectiveness study. / Prev Med 2004, 38:412鈥?0.
  133. Carpenter MJ, Hughes JR, Solomon LJ, Callas PW: Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. / J Consult Clin Psychol 2004, 72:371鈥?1.
  134. Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, / et al.: Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. / Ann Intern Med 2004, 140:426鈥?3.
  135. Hughes JR, Adams EH, Franzon MA, Maguire MK, Guary J: A prospective study of off-label use of, abuse of, and dependence on nicotine inhaler. / Tob Control 2005, 14:49鈥?4.
  136. Marsh HS, Dresler CM, Choi JH, Targett DA, Gamble ML, Strahs KR: Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study. / Clin Ther 2005, 27:1571鈥?7.
  137. Bolliger CT, van Biljon X, Axelsson A: A nicotine mouth spray for smoking cessation: a pilot study of preference, safety and efficacy. / Respiration 2007, 74:196鈥?01.
  138. Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe M, / et al.: Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. / Addiction 2008, 103:146鈥?4.
  139. Gunnell D, Irvine D, Wise L, Davies C, Martin RM: Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. / Bmj 2009, 339:b3805.
  140. Ossip DJ, Abrams SM, Mahoney MC, Sall D, Cummings KM: Adverse effects with use of nicotine replacement therapy among quitline clients. / Nicotine Tob Res 2009, 11:408鈥?7.
  141. Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, / et al.: Triple-combination pharmacotherapy for medically ill smokers: a randomized trial. / Ann Intern Med 2009, 150:447鈥?4.
  142. Oncken C, Dornelas E, Greene J, Sankey H, Glasmann A, Feinn R, / et al.: Nicotine gum for pregnant smokers: a randomized controlled trial. / Obstet Gynecol 2008, 112:859鈥?7.
  143. Matthew TP, Herity NA: Acute myocardial infarction soon after nicotine replacement therapy. / QJM 2001, 94:503鈥?.
  144. Dacosta A, Guy JM, Tardy B, Gonthier R, Denis L, Lamaud M, / et al.: Myocardial infarction and nicotine patch: a contributing or causative factor? / Eur Heart J 1993, 14:1709鈥?1.
  145. Ottervanger JP, Festen JM, de Vries AG, Stricker BH: Acute myocardial infarction while using the nicotine patch. / Chest 1995, 107:1765鈥?.
  146. Ottervanger JP, Stricker BH, Klomps HC: Transdermal nicotine: clarifications, side effects, and funding. / Jama 1993, 269:1940. author reply -1
  147. Rigotti NA, Eagle KA: Atrial fibrillation while chewing nicotine gum. / Jama 1986, 255:1018.
  148. Warner JG Jr, Little WC: Myocardial infarction in a patient who smoked while wearing a nicotine patch. / Ann Intern Med 1994, 120:695.
  149. McRobbie H, Hajek P: Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. / Addiction 2001, 96:1547鈥?1.
  150. McRobbie H, Hajek P, Gillison F: The relationship between smoking cessation and mouth ulcers. / Nicotine Tob Res 2004, 6:655鈥?.
  151. Hughes JR: Smoking and suicide: a brief overview. / Drug Alcohol Depend 2008, 98:169鈥?8.
  152. Schroeder SA: A 51-year-old woman with bipolar disorder who wants to quit smoking. / Jama 2009, 301:522鈥?1.
  153. Kyle SD, Morgan K, Espie CA: Insomnia and health-related quality of life. / Sleep Med Rev 2009.
  154. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, / et al.: Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. / Bmj 2005, 330:396.
  155. Borenstein M, Hedges L, Higgins JP, Rothstein H: / Introduction to Meta-analysis. Wiley, Chichester; 2009:312.
  156. Thomsen T, Tonnesen H, Moller AM: Effect of preoperative smoking cessation interventions on postoperative complications and smoking cessation. / Br J Surg 2009, 96:451鈥?1.
  157. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, / et al.: Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). / Eur Heart J 2009, 30:2769鈥?12.
  
• 作者单位：Edward J Mills (1)
  Ping Wu (2)
  Ian Lockhart (3)
  Kumanan Wilson (4)
  Jon O Ebbert (5)
  
  1. Faculty of Health Sciences, University of Ottawa, Ottawa, Canada
  2. Department of Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
  3. Pfizer Limited, Tadworth, Surrey, UK
  4. Ottawa Health Research Institute, Ottawa, Canada
  5. Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN, USA
  

文摘

Background Nicotine replacement therapy (NRT) is the most common form of smoking cessation pharmacotherapy and has proven efficacy for the treatment of tobacco dependence. Although expectations of mild adverse effects have been observed to be independent predictors of reduced motivation to use NRT, adverse effects associated with NRT have not been precisely quantified. Objective A systematic review and meta-analysis aimed to identify all randomized clinical trials (RCTs) of NRT versus inert controls and all observational studies to determine the magnitude of reported adverse effects with NRT. Methods Searches of 10 electronic databases from inception to November 2009 were conducted. Study selection and data extraction were carried out independently in duplicate. RCTs were pooled using a random effects method with Odds Ratio [OR] as the effect measure, while proportions were pooled from observational studies. A meta-regression analysis was applied to examine whether the nicotine patch is associated with different adverse effects from those common to orally administered NRT. Results Ninety-two RCTs involving 32,185 participants and 28 observational studies involving 145, 205 participants were identified. Pooled RCT evidence of varying NRT formulations found an increased risk of heart palpitations and chest pains (OR 2.06, 95% Confidence Interval [CI] 1.51-2.82, P < 0.001); nausea and vomiting (OR 1.67, 95% CI 1.37-2.04, P < 0.001); gastrointestinal complaints (OR 1.54, 95% CI, 1.25-1.89, P < 0.001); and insomnia (OR 1.42, 95% CI, 1.21-1.66, P < 0.001). Pooled evidence specific to the NRT patch found an increase in skin irritations (OR 2.80, 95% CO, 2.28-3.24, P < 0.001). Orally administered NRT was associated with mouth and throat soreness (OR 1.87, 95% CI, 1.36-2.57, P < 0.001); mouth ulcers (OR 1.49, 95% CI, 1.05-2.20, P < 0.001); hiccoughs (OR 7.68, 95% CI, 4.59-12.85, P < 0.001) and coughing (OR 2.89, 95% CI, 1.92-4.33, P < 0.001). There was no statistically significant increase in anxiety or depressive symptoms associated with NRT use. Non-comparative observational studies demonstrated the prevalence of these events in a broad population. Conclusion The use of NRT is associated with a variety of side effects. In addition to counseling and medical monitoring, clinicians should inform patients of potential side effects which are associated with the use of NRT for the treatment of tobacco dependence.